Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20061995HPVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS20031176HPVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS20065987HPVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS20061884HPVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS20061827HPVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS20062072HPVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS20038159HPVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS20068307HPVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS20061404HPVENSG00000106546.14protein_codingAHRNoNo196P35869
TVIS20016969HPVENSG00000106546.14protein_codingAHRNoNo196P35869
TCGA Plot Options
Drug Information
GeneAHR
DrugBank IDDB01097
Drug NameLeflunomide
Target IDBE0003721
UniProt IDP35869
Regulation Typeagonist
PubMed IDs20957046; 17327465
CitationsO'Donnell EF, Saili KS, Koch DC, Kopparapu PR, Farrer D, Bisson WH, Mathew LK, Sengupta S, Kerkvliet NI, Tanguay RL, Kolluri SK: The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor. PLoS One. 2010 Oct 1;5(10). pii: e13128. doi: 10.1371/journal.pone.0013128.@@Hu W, Sorrentino C, Denison MS, Kolaja K, Fielden MR: Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol Pharmacol. 2007 Jun;71(6):1475-86. Epub 2007 Feb 27.
GroupsApproved; Investigational
Direct ClassificationAromatic anilides
SMILESCC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F
Pathways
PharmGKBPA450192
ChEMBLCHEMBL960